Phase II Trial of Cabozantinib Plus Nivolumab in Patients With Non–Clear-Cell Renal Cell Carcinoma and Genomic Correlates

JOURNAL ARTICLE published 20 July 2022 in Journal of Clinical Oncology

Authors: Chung-Han Lee | Martin H. Voss | Maria Isabel Carlo | Ying-Bei Chen | Mark Zucker | Andrea Knezevic | Robert A. Lefkowitz | Natalie Shapnik | Chloe Dadoun | Ed Reznik | Neil J. Shah | Colette Ngozi Owens | Deaglan Joseph McHugh | David Henry Aggen | Andrew Leonard Laccetti | Ritesh Kotecha | Darren R. Feldman | Robert J. Motzer